Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer.

Deneka, Alexander Y; Einarson, Margret B; Bennett, John; Nikonova, Anna S; Elmekawy, Mohamed; Zhou, Yan; Lee, Jong Woo; Burtness, Barbara A; Golemis, Erica A

Deneka, Alexander Y; Einarson, Margret B; Bennett, John; Nikonova, Anna S; Elmekawy, Mohamed; Zhou, Yan; Lee, Jong Woo; Burtness, Barbara A; Golemis, Erica A.

Afiliación

Deneka AY; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Einarson MB; Department of Biochemistry and Biotechnology, Kazan Federal University, 420000 Kazan, Russia.
Bennett J; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Nikonova AS; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Elmekawy M; Department of Biology, Chestnut Hill College, Philadelphia, PA 19118, USA.
Zhou Y; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Lee JW; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Burtness BA; Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.
Golemis EA; Bioinformatics and Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Cancers (Basel) ; 12(2)2020 Jan 28.

Article en En | MEDLINE | ID: mdl-32012873

Palabras clave

adavosertib; head and neck cancer; mitotic catastrophe; prexasertib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google